Document Detail


Matrikines and the lungs.
MedLine Citation:
PMID:  22366287     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
The extracellular matrix is a complex network of fibrous and nonfibrous molecules that not only provide structure to the lung but also interact with and regulate the behaviour of the cells which it surrounds. Recently it has been recognised that components of the extracellular matrix proteins are released, often through the action of endogenous proteases, and these fragments are termed matrikines. Matrikines have biological activities, independent of their role within the extracellular matrix structure, which may play important roles in the lung in health and disease pathology. Integrins are the primary cell surface receptors, characterised to date, which are used by the matrikines to exert their effects on cells. However, evidence is emerging for the need for co-factors and other receptors for the matrikines to exert their effects on cells. The potential for matrikines, and peptides derived from these extracellular matrix protein fragments, as therapeutic agents has recently been recognised. The natural role of these matrikines (including inhibitors of angiogenesis and possibly inflammation) make them ideal targets to mimic as therapies. A number of these peptides have been taken forward into clinical trials. The focus of this review will be to summarise our current understanding of the role, and potential for highly relevant actions, of matrikines in lung health and disease.
Authors:
Janette K Burgess; Markus Weckmann
Related Documents :
16229477 - Erythropoietin unfolding: thermodynamics and its correlation with structural features.
24198787 - Dentin matrix degradation by host matrix metalloproteinases: inhibition and clinical pe...
65177 - Reaction of peptide 89-169 of bovine myelin basic protein with 2-(2-nitrophenylsulfenyl...
23858467 - Syntaxin1a variants lacking an n-peptide or bearing the le mutation bind to munc18a in ...
23426877 - Cyclization of the antimicrobial peptide gomesin with native chemical ligation: influen...
8089137 - A novel alpha-amylase inhibitor from amaranth (amaranthus hypocondriacus) seeds.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-2-16
Journal Detail:
Title:  Pharmacology & therapeutics     Volume:  -     ISSN:  1879-016X     ISO Abbreviation:  -     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-2-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7905840     Medline TA:  Pharmacol Ther     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012. Published by Elsevier Inc.
Affiliation:
Cell Biology, Woolcock Institute of Medical Research, Sydney, NSW, Australia; Discipline of Pharmacology, The University of Sydney, Sydney, NSW, Australia; The Cooperative Research Centre for Asthma and Airways, Sydney, NSW, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Appetite, energy intake and resting metabolic responses to 60 min treadmill running performed in a f...
Next Document:  Histone deacetylase (HDAC) inhibitors and regulation of TRAIL-induced apoptosis.